Skip to content

The clinical trial to evaluate the efficacy of [11C]K-2 in refractory epilepsy patients undergoing anterior temporal lobectomy

The clinical trial to evaluate the efficacy of [11C]K-2 in refractory epilepsy patients undergoing anterior temporal lobectomy - The clinical trial to evaluate the efficacy of [11C]K-2 in epilepsy patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025090
Enrollment
8
Registered
2016-12-01
Start date
2016-11-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory epilepsy patients

Interventions

Sponsors

Yokohama City University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.refractory epilepsy patients(mesial temporal lobe epilepsy) 2.patinets for anterior temporal lobectomy(ATL) 3.patients who are without cerebral surgery on the same side of ATL 4.patients who are 20 years or older 5.patients who can consent to this study by oneself

Exclusion criteria

Exclusion criteria: 1.patients who have significant abnormalities insides the brains 2.patients who have experienced the electric stimulation therapy 3.patients who undergo artificial dialysis 4.patients who have severe liver dysfunction 5.patients who have tatoo 6.claustrophobic patients 7.breast-feeding mothers, expecting mothers, females who desire to be a mother 8.patients who desire to bear a child within this study period 9.patients who take Fycompa 10.patients who underwent nuclear medicine examination within one-week before this registarion 11.patients who underwent other clinical trials using unapproved nuclear medicine examination within six month before this registarion 12.patients who underwent other clinical trials within 12 weeks before this registarion 13.patients whom study doctors consider unappropriate

Design outcomes

Primary

MeasureTime frame
The correlation of the AMPA receptors densities examined by biochemical study and [11C]K-2 PET study

Secondary

MeasureTime frame
The adverse events occured in patients during 7days after PET scan

Countries

Japan

Contacts

Public Contactsano akane

Yokohama City University, School of Medicine Department of Physiology

akane@med.yokohama-cu.ac.jp045-787-2579

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026